213 related articles for article (PubMed ID: 32384116)
21. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.
Niu P; Zhao G; Deng Y; Sun S; Wang W; Zhou Y; Tan W
Sci China Life Sci; 2018 Oct; 61(10):1280-1282. PubMed ID: 30091015
[No Abstract] [Full Text] [Related]
22. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.
Du L; Zhao G; Yang Y; Qiu H; Wang L; Kou Z; Tao X; Yu H; Sun S; Tseng CT; Jiang S; Li F; Zhou Y
J Virol; 2014 Jun; 88(12):7045-53. PubMed ID: 24719424
[TBL] [Abstract][Full Text] [Related]
23. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
[TBL] [Abstract][Full Text] [Related]
24. Antibody-mediated protection against MERS-CoV in the murine model.
New RRC; Moore BD; Butcher W; Mahood R; Lever MS; Smither S; O'Brien L; Weller SA; Bayliss M; Gibson LCD; Macleod C; Bogus M; Harvey R; Almond N; Williamson ED
Vaccine; 2019 Jul; 37(30):4094-4102. PubMed ID: 31178378
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
[TBL] [Abstract][Full Text] [Related]
26. Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD.
Wang C; Hua C; Xia S; Li W; Lu L; Jiang S
Viruses; 2019 Jan; 11(1):. PubMed ID: 30621343
[TBL] [Abstract][Full Text] [Related]
27. Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.
Agrawal AS; Ying T; Tao X; Garron T; Algaissi A; Wang Y; Wang L; Peng BH; Jiang S; Dimitrov DS; Tseng CT
Sci Rep; 2016 Aug; 6():31629. PubMed ID: 27538452
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
[TBL] [Abstract][Full Text] [Related]
29. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus.
Lee JH; Kim JW; Lee HE; Song JY; Cho AH; Hwang JH; Heo K; Lee S
Virus Res; 2024 Jul; 345():199383. PubMed ID: 38697296
[TBL] [Abstract][Full Text] [Related]
30. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.
Ying T; Du L; Ju TW; Prabakaran P; Lau CC; Lu L; Liu Q; Wang L; Feng Y; Wang Y; Zheng BJ; Yuen KY; Jiang S; Dimitrov DS
J Virol; 2014 Jul; 88(14):7796-805. PubMed ID: 24789777
[TBL] [Abstract][Full Text] [Related]
31. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
[TBL] [Abstract][Full Text] [Related]
32. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
[TBL] [Abstract][Full Text] [Related]
33. MERS-CoV spike protein: a key target for antivirals.
Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
[TBL] [Abstract][Full Text] [Related]
34. Human β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity.
Kim J; Yang YL; Jang SH; Jang YS
Virol J; 2018 Aug; 15(1):124. PubMed ID: 30089512
[TBL] [Abstract][Full Text] [Related]
35. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
[TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y; Shang J; Sun S; Tai W; Chen J; Geng Q; He L; Chen Y; Wu J; Shi Z; Zhou Y; Du L; Li F
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826992
[TBL] [Abstract][Full Text] [Related]
37. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization.
Liu R; Wang J; Shao Y; Wang X; Zhang H; Shuai L; Ge J; Wen Z; Bu Z
Antiviral Res; 2018 Feb; 150():30-38. PubMed ID: 29246504
[TBL] [Abstract][Full Text] [Related]
38. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
Tang XC; Agnihothram SS; Jiao Y; Stanhope J; Graham RL; Peterson EC; Avnir Y; Tallarico AS; Sheehan J; Zhu Q; Baric RS; Marasco WA
Proc Natl Acad Sci U S A; 2014 May; 111(19):E2018-26. PubMed ID: 24778221
[TBL] [Abstract][Full Text] [Related]
39. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Ying T; Li H; Lu L; Dimitrov DS; Jiang S
Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
[TBL] [Abstract][Full Text] [Related]
40. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
Iwata-Yoshikawa N; Okamura T; Shimizu Y; Kotani O; Sato H; Sekimukai H; Fukushi S; Suzuki T; Sato Y; Takeda M; Tashiro M; Hasegawa H; Nagata N
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
